Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check7 days agoChange DetectedNo significant changes detected in the study's core content between versions; the primary information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision tag, replacing the previous v3.1.0. This updates core content with current operating status guidance and versioning.SummaryDifference1%

- Check43 days agoChange Detected- Added version indicator Revision: v3.1.0. - Removed several substantive topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained a prior version Revision: v3.0.2, suggesting a reorganization and narrowing of content scope with a move to a newer version.SummaryDifference0.2%

- Check50 days agoChange DetectedRemoved the 'Back to Top' link; no other content changes detected.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2, indicating a new version release.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page has updated the citation for a study on type 2 inflammation biomarkers in COPD, reflecting a new publication date and revision version.SummaryDifference0.3%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.